35 found
Order:
Disambiguations
Jeffrey P. Kahn [35]Jeffrey Paul Kahn [1]
  1.  57
    Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations.Susan M. Wolf, Frances P. Lawrenz, Charles A. Nelson, Jeffrey P. Kahn, Mildred K. Cho, Ellen Wright Clayton, Joel G. Fletcher, Michael K. Georgieff, Dale Hammerschmidt, Kathy Hudson, Judy Illes, Vivek Kapur, Moira A. Keane, Barbara A. Koenig, Bonnie S. LeRoy, Elizabeth G. McFarland, Jordan Paradise, Lisa S. Parker, Sharon F. Terry, Brian Van Ness & Benjamin S. Wilfond - 2008 - Journal of Law, Medicine and Ethics 36 (2):219-248.
    No consensus yet exists on how to handle incidental fnd-ings in human subjects research. Yet empirical studies document IFs in a wide range of research studies, where IFs are fndings beyond the aims of the study that are of potential health or reproductive importance to the individual research participant. This paper reports recommendations of a two-year project group funded by NIH to study how to manage IFs in genetic and genomic research, as well as imaging research. We conclude that researchers (...)
    Direct download (8 more)  
     
    Export citation  
     
    Bookmark   96 citations  
  2.  59
    Research Led by Participants: A New Social Contract for a New Kind of Research.Effy Vayena, Roger Brownsword, Sarah Jane Edwards, Bastian Greshake, Jeffrey P. Kahn, Navjoyt Ladher, Jonathan Montgomery, Daniel O'Connor, Onora O'Neill, Martin P. Richards, Annette Rid, Mark Sheehan, Paul Wicks & John Tasioulas - 2016 - Journal of Medical Ethics 42 (4):216-219.
    Direct download (12 more)  
     
    Export citation  
     
    Bookmark   11 citations  
  3.  69
    Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary Approach for an Emerging Field.Leili Fatehi, Susan M. Wolf, Jeffrey McCullough, Ralph Hall, Frances Lawrenz, Jeffrey P. Kahn, Cortney Jones, Stephen A. Campbell, Rebecca S. Dresser, Arthur G. Erdman, Christy L. Haynes, Robert A. Hoerr, Linda F. Hogle, Moira A. Keane, George Khushf, Nancy M. P. King, Efrosini Kokkoli, Gary Marchant, Andrew D. Maynard, Martin Philbert, Gurumurthy Ramachandran, Ronald A. Siegel & Samuel Wickline - 2012 - Journal of Law, Medicine and Ethics 40 (4):716-750.
    Nanomedicine is yielding new and improved treatments and diagnostics for a range of diseases and disorders. Nanomedicine applications incorporate materials and components with nanoscale dimensions where novel physiochemical properties emerge as a result of size-dependent phenomena and high surface-to-mass ratio. Nanotherapeutics and in vivo nanodiagnostics are a subset of nanomedicine products that enter the human body. These include drugs, biological products, implantable medical devices, and combination products that are designed to function in the body in ways unachievable at larger scales. (...)
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark   9 citations  
  4. Sunset on the RAC: When Is It Time to End Special Oversight of an Emerging Biotechnology?Jeffrey P. Kahn & Anna C. Mastroianni - 2018 - American Journal of Bioethics 18 (12):1-2.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  5.  30
    The Task Force Responds.Baruch Brody, Nancy Dubler, Jeff Blustein, Arthur Caplan, Jeffrey P. Kahn, Nancy Kass, Bernard Lo, Jonathan Moreno, Jeremy Sugarman & Laurie Zoloth - 2002 - Hastings Center Report 32 (3):22-23.
  6.  21
    CONCEPTION to Obtain Hematopoietic Stem Cells.John A. Robertson, Jeffrey P. Kahn & John E. Wagner - 2002 - Hastings Center Report 32 (3):34-40.
  7.  31
    Using Preimplantation Genetic Diagnosis to Create a Stem Cell Donor: Issues, Guidelines & Limits.Susan M. Wolf, Jeffrey P. Kahn & John E. Wagner - 2003 - Journal of Law, Medicine and Ethics 31 (3):327-339.
    Successful preimplantation genetic diagnosis to avoid creating a child affected by a genetically-based disorder was reported in 1989. Since then PGD has been used to biopsy and analyze embryos created through in viuo fertilization to avoid transferring to the mother’s uterus an embryo affected by a mutation or chromosomal abnormality associated with serious illness. PGD to avoid serious and early-onset illness in the child-to-be is widely accepted. PGD prevents gestation of an affected embryo and reduces the chance that the parents (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   6 citations  
  8.  59
    Creating a Stem Cell Donor: A Case Study in Reproductive Genetics.Jeffrey P. Kahn & Anna C. Mastroianni - 2004 - Kennedy Institute of Ethics Journal 14 (1):81-96.
    : During the nearly 10 years since its introduction, preimplantation genetic diagnosis (PGD) has been used predominantly to avoid giving birth to a child with identified genetic disease. Recently, PGD was used by a couple not only to test IVF-created embryos for genetic disease, but also to test for a nondisease trait related to immune compatibility with a child in the family in need of an hematopoetic stem cell transplant. This article describes the case, raises some ethical and policy issues, (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  9.  57
    Three Views of Organ Procurement Policy: Moving Ahead or Giving Up?Jeffrey P. Kahn - 2003 - Kennedy Institute of Ethics Journal 13 (1):45-50.
    : The supply of organs for transplant remains inadequate to meet the needs of waiting patients, in spite of many programs and approaches to increase rates of donation. Over the years there have been numerous proposals to introduce schemes that would move toward the outright sale of organs. Three articles in this issue of the Journal propose methods for increasing organ supply—two by moving toward a market approach and the third by advocating a change in social culture. All three suffer (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  10.  9
    Genetic Harm: Bitten by the Body That Keeps You?Jeffrey P. Kahn - 1991 - Bioethics 5 (4):289–308.
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  11.  5
    Using Preimplantation Genetic Diagnosis to Create a Stem Cell Donor: Issues, Guidelines & Limits.Susan M. Wolf, Jeffrey P. Kahn & John E. Wagner - 2003 - Journal of Law, Medicine and Ethics 31 (3):327-339.
    Successful preimplantation genetic diagnosis to avoid creating a child affected by a genetically-based disorder was reported in 1989. Since then PGD has been used to biopsy and analyze embryos created through in viuo fertilization to avoid transferring to the mother’s uterus an embryo affected by a mutation or chromosomal abnormality associated with serious illness. PGD to avoid serious and early-onset illness in the child-to-be is widely accepted. PGD prevents gestation of an affected embryo and reduces the chance that the parents (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  12.  31
    American College of Epidemiology Ethics Guidelines: Foundations and Dissemination.Robert E. McKeown, Douglas L. Weed, Jeffrey P. Kahn & Michael A. Stoto - 2003 - Science and Engineering Ethics 9 (2):207-214.
    Epidemiology is a core science of public health, focusing on research related to the distribution and determinants of both positive and adverse health states and events and on application of knowledge gained to improve public health. The American College of Epidemiology (ACE) is a professional organization devoted to the professional practice of epidemiology. As part of that commitment, and in response to concerns for more explicit attention to core values and duties of epidemiologists in light of emerging issues and increased (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  13.  33
    Bioethics Matures: The Field Faces the Future.Susan M. Wolf & Jeffrey P. Kahn - 2005 - Hastings Center Report 35 (4):22-24.
  14.  16
    Genetic Testing and the Future of Disability Insurance: Ethics, Law & Policy.Susan M. Wolf & Jeffrey P. Kahn - 2007 - Journal of Law, Medicine and Ethics 35 (s2):6-32.
    Predictive genetic testing poses fundamental questions for disability insurance, a crucial resource funding basic needs when disability prevents income from work. This article, from an NIH-funded project, presents the first indepth analysis of the challenging issues: Should disability insurers be permitted to consider genetics and exclude predicted disability? May disabilities with a recognized genetic basis be excluded from coverage as pre-existing conditions? How can we assure that private insurers writing individual and group policies, employers, and public insurers deal competently and (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  15.  11
    What Happens When Politics Discovers Bioethics?Jeffrey P. Kahn - 2006 - Hastings Center Report 36 (3):10-10.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  16.  2
    Genetic Testing and the Future of Disability Insurance: Ethics, Law & Policy.Susan M. Wolf & Jeffrey P. Kahn - 2007 - Journal of Law, Medicine and Ethics 35 (S2):6-32.
    Genetic testing poses fundamental questions for insurance. Testing can predict a low probability of future illness and disability, which can help promote the insurability of individuals with a family history of genetic risk, but it can also invite insurers to reject applicants, increase premiums, exclude people with certain illnesses and disabilities, and otherwise adjust the underwriting processes for individuals with certain genotypes. In the workplace, these issues may cause employers who offer or pay for insurance to alter their hiring behavior, (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  17.  2
    Genetic Harm: Bitten by the Body That Keeps You?Jeffrey P. Kahn - 1991 - Bioethics 5 (4):289-308.
    Direct download  
     
    Export citation  
     
    Bookmark   1 citation  
  18. Cross-Cultural Biotechnology: A Reader.Stella Gonzalez Arnal, Donald Chalmers, David Kum-Wah Chan, Margaret Coffey, Jo Ann T. Croom, Mylène Deschênes, Henrich Ganthaler, Yuri Gariev, Ryuichi Ida, Jeffrey P. Kahn, Martin O. Makinde, Anna C. Mastroianni, Katharine R. Meacham, Bushra Mirza, Michael J. Morgan, Dianne Nicol, Edward Reichman, Susan E. Wallace & Larissa P. Zhiganova - 2004 - Rowman & Littlefield Publishers.
    This book is a rich blend of analyses by leading experts from various cultures and disciplines. A compact introduction to a complex field, it illustrates biotechnology's profound impact upon the environment and society. Moreover, it underscores the vital relevance of cultural values. This book empowers readers to more critically assess biotechnology's value and effectiveness within both specific cultural and global contexts.
     
    Export citation  
     
    Bookmark   1 citation  
  19.  19
    By Author BAGHERI, Alireza. Criticism of “Brain.Tom L. Beauchamp, Howard Brody, Franklin G. Miller, Alexander S. Curtis, Martina Darragh, Patricia Milmoe, Ronald M. U. S. Green, Sharona Hoffman, Edmund G. Howe & Jeffrey P. Kahn - 2003 - Kennedy Institute of Ethics Journal 13 (4):407-09.
  20.  1
    Toward Justice in Human Subjects ResearchBeyond Consent: Seeking Justice in Research.Lisa Sowle Cahill, Jeffrey P. Kahn, Anna C. Mastroianni & Jeremy Sugarman - 2000 - Hastings Center Report 30 (4):45.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  21.  8
    Introduction.P. Kahn Jeffrey & C. Mastroianni Anna - 1996 - Kennedy Institute of Ethics Journal 6 (3):ix-xi.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  22.  9
    Baseball, Alcohol and Public Health.Jeffrey P. Kahn - 2007 - American Journal of Bioethics 7 (7):3.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  23. Beyond Consent: Seeking Justice in Research.Jeffrey P. Kahn, Anna C. Mastroianni & Jeremy Sugarman (eds.) - 1998 - Oup Usa.
    Beyond Consent examines the concept of justice, and its application to human subject research, through the different lenses of various research populations: children, the vulnerable sick, captive and convenient populations, women, people of colour, and subjects in international settings. Separate chapters address the evolution of research policies, implications of the concept of justice for the future of human subject research, and the ramifications of this concept throughout the research enterprise.
    No categories
     
    Export citation  
     
    Bookmark   13 citations  
  24.  10
    Commentary on Zohar's "Prospects For'genetic Therapy'- Can a Person Benefit From Being Altered?".Jeffrey P. Kahn - 1991 - Bioethics 5 (4):312–317.
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark  
  25.  2
    Commentary on Zohar's “Prospects for‘Genetic Therapy’‐ Can a Person Benefit From Being Altered?”.Jeffrey P. Kahn - 1991 - Bioethics 5 (4):312-317.
    Direct download  
     
    Export citation  
     
    Bookmark  
  26.  3
    Commentary: Who's Afraid of the RAC? Lessons From the Oversight of Controversial Science.Jeffrey P. Kahn - 2009 - Journal of Law, Medicine and Ethics 37 (4):685-687.
    This commentary asks what we can learn from our oversight of controversial science and how can we do better in the future? After briefly examining the history of gene transfer research oversight, some observations are offered for the oversight of nanobiotechnology and other emerging areas of science.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  27.  1
    Commentary: Who's Afraid of the RAC? Lessons From the Oversight of Controversial Science.Jeffrey P. Kahn - 2009 - Journal of Law, Medicine and Ethics 37 (4):685-687.
    No categories
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  28.  2
    Letter to the Editor.Jeffrey P. Kahn - 2005 - American Journal of Bioethics 5 (3):W13-W13.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  29.  24
    Organs and Stem Cells: Policy Lessons and Cautionary Tales.Jeffrey P. Kahn - 2007 - Hastings Center Report 37 (2):11-12.
  30.  4
    Understanding the Role of Genetics in Disability Insurance.Jeffrey P. Kahn & Susan M. Wolf - 2007 - Journal of Law, Medicine and Ethics 35 (s2):5-5.
  31.  1
    Understanding the Role of Genetics in Disability Insurance.Jeffrey P. Kahn & Susan M. Wolf - 2007 - Journal of Law, Medicine and Ethics 35 (S2):5-5.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  32.  4
    Why Public Health and Politics Don't Mix.Jeffrey P. Kahn - 2007 - American Journal of Bioethics 7 (11):3 – 4.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  33. Oxford Handbook of Public Health Ethics.Anna C. Mastroianni, Jeffrey P. Kahn & Nancy E. Kass (eds.) - 2019 - Oup Usa.
    Public health raises critical ethics issues and concerns, making public heath ethics an essential topic for students and public health professionals. The 73 chapters in this volume examine public health ethics across a broad range of public health topics both in the U.S. and globally. It is the first ever comprehensive collection devoted to public health ethics.
    No categories
     
    Export citation  
     
    Bookmark  
  34. Conception.John A. Robertson, Jeffrey P. Kahn & John E. Wagner - forthcoming - Hastings Center Report.
     
    Export citation  
     
    Bookmark  
  35. Clinical, Ethical, and Legal Issues in Using Preimplantation Genetic Diagnosis to Create a Stem Cell Donor.Susan M. Wolf, Jeffrey P. Kahn & John E. Wagner - 2003 - Journal of Law, Medicine and Ethics 31 (3):327-39.
    Successful preimplantation genetic diagnosis to avoid creating a child affected by a genetically-based disorder was reported in 1989. Since then PGD has been used to biopsy and analyze embryos created through in viuo fertilization to avoid transferring to the mother’s uterus an embryo affected by a mutation or chromosomal abnormality associated with serious illness. PGD to avoid serious and early-onset illness in the child-to-be is widely accepted. PGD prevents gestation of an affected embryo and reduces the chance that the parents (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations